<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>Merck.com - Product News</title>
<link>http://www.merck.com/newsroom/news-release-archive/product/</link>
<description>Merck.com - Product News</description>
<image>
	<title>Merck.com - Product News</title>
	<width>142</width>
	<height>42</height>
	<link>http://www.merck.com/newsroom/news-release-archive/product/</link>
	<url>http://www.merck.com/site_images/mercklogo-rss.jpg</url>
</image>
<item>
	<title>Higher Dose of Merck's COZAAR&amp;reg; (losartan potassium tablets) Significantly Reduced Deaths and Hospitalizations Due to Heart Failure In Investigational Study</title>
	<guid isPermaLink="false">HigherDoseofMerc11/17/2009</guid>
	<link>http://www.merck.com/newsroom/news-release-archive/product/2009_1117.html?src=rss</link>
	<pubDate>Tue, 17 Nov 2009 00:00:00 GMT</pubDate>
</item>
<item>
	<title>Merck Expresses Confidence in the Efficacy and Safety Profiles of ZETIA&amp;reg; (ezetimibe) and VYTORIN&amp;reg; (ezetimibe/simvastatin) as Effective Medicines for Managing Elevated Cholesterol</title>
	<guid isPermaLink="false">Merck ExpressesC11/15/2009</guid>
	<link>http://www.merck.com/newsroom/news-release-archive/product/2009_1115.html?src=rss</link>
	<pubDate>Wed, 21 Oct 2009 00:00:00 GMT</pubDate>
</item>
<item>
	<title>CDC Advisory Committee on Immunization Practices Votes for Permissive Use and for Vaccines for Children Funding for GARDASIL&amp;reg; for Boys and Young Men</title>
	<guid isPermaLink="false">CDCAdvisoryCommi10/21/2009</guid>
	<link>http://www.merck.com/newsroom/news-release-archive/product/2009_1021.html?src=rss</link>
	<pubDate>Wed, 21 Oct 2009 00:00:00 GMT</pubDate>
</item>
</channel>
</rss>